Second Report of the p.Leu874Pro Missense Variant in EPHB4 in a Family With Capillary Malformation‐Arteriovenous Malformation Syndrome (CM‐AVM) Syndrome

Laura E. Goeser,Leah Lalor,Yvonne E. Chiu,Michael Muriello
DOI: https://doi.org/10.1002/ajmg.a.63898
2024-10-23
American Journal of Medical Genetics Part A
Abstract:Capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome is characterized by the presence of multiple small (1–2 cm in diameter) capillary malformations of the skin. This disorder has been described as two distinct entities: CM‐AVM1 and CM‐AVM2. The diagnosis of these disorders has been associated with pathogenic variants in the RASA1 gene for RASA1‐CM‐AVM, formerly known as CM‐AVM1, and, more recently, the EPHB4 genes for EPHB4‐CM‐AVM, formerly known as CM‐AVM2. Affected patients with either type may also have arteriovenous malformations and fistulas, which can cause life‐threatening bleeding, congestive heart failure, or neurologic consequences such as stroke. These syndromes are typically either sporadic or inherited in an autosomal dominant manner with variable expressivity. We report a case series of a father and three daughters who have clinically diagnosed EPHB4‐CM‐AVM syndrome who were found to have a variant of uncertain significance (VUS) in EPHB4 that has only been reported once prior.
genetics & heredity
What problem does this paper attempt to address?